A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
5
References
8
Citations
NaN
KQI